High-risk human papillomavirus persistence and other molecular genetic predictors for cervical intraepithelial neoplasias


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To analyze the signif icance of high-risk human papillomavirus (hrHPV) persistence, viral load, and mRNA expression of the MKI67, CDKN2A, PGR, and BCI2 genes in predicting the development of squamous intraepithelial lesions (SIL). Subjects and methods. The investigation included 85 women (mean age, 34+11 years) with NIIM cytology and positive hrHPV. A comprehensive clinical and laboratory examination involved HPV typing with viral load assessment; real-time PCR assay of the mRNA expression of human genes; liquid cytology; extended colposcopy once every 12 months during 2-year follow-up, and cervical biopsy (if indicated). Results. There were 2 groups: la) 52 (61%) patients with transient papillomavirus infection and a persistent negative response, lb) 12 (14%) with transient infection and an unstable negative response; 2) 21 (25%) with persistent hrHPV. There was a worse colposcopic pattern in 12 (57%) patients in the persistent hrHPV group. There was persistence of HPV types (16, 31, 39, 52, 18, and 68). Histologically, SII was verified for 2 years only in Group II: ISII in 10(47%) and HSII in 1 (5%); 6 (55%) of them had changes in the mRNA expression of the MKI67, CDKN2A, PGR and BCI2 genes. Conclusion. Persistent hrHPV with changes in the mRNA expression of the MKI67, CDKN2A, PGR, and BCI2 genes and in the colposcopic pattern are considered as markers for SII progression.

Full Text

Restricted Access

About the authors

Elena G. Sycheva

Academician V.l. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: el.bona@mail.ru
doctor

Niso M. Nazarova

Academician V.l. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: grab2@yandex.ru
MD, PhD, Senior Researcher

Olga V. Burmenskaya

Academician V.l. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: bourmenska@mail.ru
Doctor of Biological Sciences, Senior Researcher of Laboratory molecular genetic Methods

Vera N. Prilepskaya

Academician V.l. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: VPrilepskaya@mail.ru
MD, PhD, Professor, Deputy Director for Science

Dmitry Yu. Trofimov

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Professor Doctor of Biological Sciences, Head of the Department of Clinical and Molecular Genetics

Gennady T. Sukhikh

Academician V.l. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: g_sukhikh@oparina4.ru
MD, Professor, Academical of the Russian Academy of Sciences, Director

References

  1. Sasiow D., Solomon D., Lawson H.W., Killackey M., Kulasingam S.L., Cain J. et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am. J. Clin. Pathol. 2012; 137(4): 516-42.
  2. Soto-De León S.C., Del Rio-Ospina L., Camargo М., Sánchez R-, Moreno-Pérez D.A., Pérez-Prados A. et al. Persistence, clearance and reinfection regarding six high risk human papillomavirus types in Colombian women: a follow-up study. BMC Infect. Dis. 2014; 14: 395.
  3. Xiao S.S.,Fan J.L.,He S.L.,Li Y.R., Wang L.Y., Yu K.N. et al. Analysis of human papillomavirus infection in 16,320 patients from a gynecology clinic in Central South China. J. Low. Genit. Tract Dis. 2016; 20(4): 327-31.
  4. Kang W.D., Ju U.C., Kim S.M. Is human papillomavirus genotype important in predicting disease progression in women with biopsy-proven negative or CIN1 of atypical squamous cell of undetermined significance (ASC-US) cytology? Gynecol. Oncol. 2018; 148(2): 305-10. https://doi.Org/10.1016/j.ygyno.2017.11.025
  5. Quaas J., Reich O., Frey Tirri B., Kuppers V. Explanation and use of the colposcopy terminology of the IFCPC (International Federation for Cervical Pathology and Colposcopy) Rio 2011. Geburtshilfe Frauenheilkd. 2013; 73(9): 904-7.
  6. Burd E.M. Human papillomavirus laboratory testing: the changing paradigm. Clin. Microbiol. Rev. 2016; 29(2): 291-319.
  7. Стародубцева Н.Л., Назарова H.M., Зардиашвили М.Д., Бурменская О.В., Бугрова А.Е., Чаговец В.В., Кононихин А.С., Трофимов Д.Ю., Франкевич В.Е., Сухих Т.Т. Комбинация протеомного и транскриптомного подходов для определения риска малигнизации неоплазий шейки матки при папилломавирусной инфекции. Акушерство и гинекология. 2017; 5: 64-71.
  8. Бурменская O.B., Назарова H.M., Прилепская B.H., Мзарелуа Т.М., Бестаева Н.В., Трофимов Д.Ю., Сухих Т.Т. Прогнозирование риска развития и прогрессирования цервикальных интраэпителиальных неоплазий, ассоциированных с папилломавирусной инфекцией. Акушерство и гинекология. 2016; 2: 92-8.
  9. Arbyn М., Tommasino М., Depuydt C., Dillner J. Are 20 human papillomavirus types causing cervical cancer? J. Pathol. 2014; 234(4): 431-5.
  10. Halec G., Alemany L., Lloveras B., Schmitt М., Alejo М., Bosch E.X. et al. Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer. J. Pathol. 2014; 234(4): 441-51.
  11. Dillner J. Prevention of human papillomavirus-associated cancers. Semin. Oncol. 2015; 42(2): 272-83. http://dx.doi.Org/10.1053/j.seminoncol.2014.12.028

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies